Literature DB >> 7023745

Attenuation of the stress response to cardiopulmonary bypass by the addition of pulsatile flow.

D M Philbin, F H Levine, K Kono, C H Coggins, J Moss, E E Slater, M J Buckley.   

Abstract

The effect of pulsatile flow during cardiopulmonary bypass on the hormonal stress response was studied in 26 patients. Thirteen had routine and 13 had pulsatile bypass with an average pulse pressure of 30 mm Hg. Plasma vasopressin levels were significantly elevated during bypass in both groups, but were lower with pulsation (66 +/- 11 vs 36.3 pg/ml, p less than 0.05). Epinephrine levels increased in both groups during bypass, but were higher after bypass (1179 +/- 448 vs 713 +/- 140 pg/ml, p less than 0.05) and in the recovery room (1428 +/- 428 vs 699 +/- 155 pg/ml, p less than 0.05) in the nonpulsatile group. The same response was noted in the norepinephrine levels (924 +/- 225 vs 465 +/- 90 pg/ml, p less than 0.05; 1015 +/- 491 vs 717 +/- 112 pg/ml, p less than 0.05). There were no significant changes in renin activity in either group, but the increase after cardiopulmonary bypass was greater in the nonpulsatile group (2.0 +/- 0.7 vs 1.36 +/- 0.4 ng/ml/hr, NS). These data suggest that pulsatile flow significantly attenuates the vasopressin and catecholamine stress response to cardiopulmonary bypass. This may explain the increased flow requirements and better tissue perfusion and organ function and the decreased incidence of postoperative hypertension after bypass using pulsatile flow.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7023745     DOI: 10.1161/01.cir.64.4.808

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Sustained effects of plasma norepinephrine levels on femoral-radial pressure gradient after cardiopulmonary bypass.

Authors:  R Nakayama; T Goto; I Kukita; R Sakata
Journal:  J Anesth       Date:  1993-01       Impact factor: 2.078

2.  Persistent endocrine stress response in patients undergoing cardiac surgery.

Authors:  A Roth-Isigkeit; J Brechmann; L Dibbelt; H H Sievers; W Raasch; P Schmucker
Journal:  J Endocrinol Invest       Date:  1998-01       Impact factor: 4.256

3.  A pulsatile pump for cardiopulmonary bypass and its clinical use.

Authors:  Y Sasaki; T Kawai; K Nishiyama; Y Murayama; S Toda; T Wada; K Kitaura; S Sato; M Kadowaki; Y Kanki
Journal:  Jpn J Surg       Date:  1988-09

4.  Plasma catecholamine changes during cardiopulmonary bypass: a randomised double blind comparison of trimetaphan camsylate and sodium nitroprusside.

Authors:  L Corr; R M Grounds; M J Brown; J G Whitwam
Journal:  Br Heart J       Date:  1986-07

5.  Experimental results and future prospects for a nonpulsatile cardiac prosthesis.

Authors:  R Yozu; L A Golding; G Jacobs; H Harasaki; Y Nose
Journal:  World J Surg       Date:  1985-02       Impact factor: 3.352

6.  Pulsatile cardiopulmonary bypass for patients with renal insufficiency.

Authors:  G N Olinger; L D Hutchinson; L I Bonchek
Journal:  Thorax       Date:  1983-07       Impact factor: 9.139

7.  Effects of pulsatile cardiopulmonary bypass on the renin-angiotensin-aldosterone system following open heart surgery.

Authors:  H Nagaoka; R Innami; H Arai
Journal:  Jpn J Surg       Date:  1988-07

8.  The outcome of pediatric patients undergoing congenital cardiac surgery under pulsatile cardiopulmonary bypass in different frequencies.

Authors:  Guanhua Li; Wen Jiang; Yu Zhang; Xiaohua Zhang; Jimei Chen; Jian Zhuang; Chengbin Zhou
Journal:  Ther Clin Risk Manag       Date:  2018-09-03       Impact factor: 2.423

9.  Efficacy of Pulsatile Flow Perfusion in Adult Cardiac Surgery: Hemodynamic Energy and Vascular Reactivity.

Authors:  Mikhail Dodonov; Francesco Onorati; Giovanni Battista Luciani; Alessandra Francica; Maddalena Tessari; Tiziano Menon; Leonardo Gottin; Aldo Domenico Milano; Giuseppe Faggian
Journal:  J Clin Med       Date:  2021-12-17       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.